The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral-domain optical coherence tomography

Ophthalmic Genetics

Volumn 35, Issue 1, 2014, Pages 47-50

  Salvatore, Serena ^a,b   Genead, Mohamed A ^b   Fishman, Gerald A ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Pangere Center for Hereditary Retinal Diseases   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cone rod dystrophy; Inherited retinal dystrophies; Macular cysts; Spectral domain optical coherence tomography

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; HUMAN; HYPO REFLECTIVE LACUNAE; IMAGING SYSTEM; MALE; MIDDLE AGED; NIGHT BLINDNESS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETINA CONE; RETINA CONE ROD DYSTROPHY; RETINA DYSTROPHY; RETINA MACULA CYSTOID EDEMA; RETINA ROD; RETINAL THICKNESS; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CYSTS; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 84893625234     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2013.804095     Document Type: Article

References (26)

1. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis 2007;2:1-7.
2. Traboulsi EI. Genetic diseases of the eye, 2nd ed. (Oxford Monographs on Medical Genetics). Oxford: Oxford University Press; 2011:410-413.
3. Hamel CP, Griffoin JM, Bazalgette C, et al. Génétique moléculaire des rétinopathies pigmentaires: identification de mutations des gènes CHM, RDS, RHO, RPE65, USH2A et XLRS1. J Fr Ophtalmol 2000;23:985-995.
4. Krill AE, Deutman AF, Fishman M. The cone degenerations. Documenta Ophthalmol 1973;35:1-80.
5. Stanga PE, Downes SM, Ahuja RM, et al. Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results. Int Ophthalmol 2001;23:321-325.
6. Hajali M, Fishman GA. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye 2009;23:915-919.
7. Genead MA, McAnany JJ, Fishman GA. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina 2012;32:826-833.
8. Vannas-Sulonen K. Progression of gyrate atrophy of the choroid and retina. A long-term follow-up by fluorescein angiography. Acta Ophthalmologica 1987;65:101-109.
9. Vasconcelos-Santos DV, Magalha?es EP, Nehemy MB. Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report. Arq Bras Oftalmol 2007;70:858-861.
10. Genead MA, Fishman GA, McAnany JJ. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Documenta Ophthalmol 2010;121:231-240.
11. Gregori NZ, Berrocal AM, Gregori G, et al. Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis. Br J Ophthalmol 2009;93: 373-378.
12. Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 2010;128:1146-1150.
13. Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmologica Scandinavica 2005;83:248-251.
14. Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850-858.
15. Genead MA, Fishman GA, Walia S. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol 2010;128:190-197.
16. Catier A, Tadayoni R, Paques M, et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 2005;140: 200-206.
17. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011;31:1609-1619.
18. Jovanovic BD, Zalenski RJ. Safety evaluation and confidence intervals when the number of observed events is small or zero. Ann Emerg Med 1997;30:301-306.
19. Fishman GA, Stone EM, Eliason DA, et al. ABCA4 gene sequence variations in patients with autosomal recessive cone-rod dystrophy. Arch Ophthalmol 2003;121: 851-855.
20. Ghajarnia M, Gorin MB. Acetazolamide in the treatment of X-linked retinoschisis maculopathy. Arch Ophthalmol 2007;125:571-573.
21. Iannaccone A, Fung KH, Eyestone ME, et al. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. Am J Ophthalmol 2009; 147:307-312.
22. Fishman GA, Cunha-Vaz J, Salzano T. Vitreous fluorophotometry in patients with retinitis pigmentosa. Arch Ophthalmol 1981;99:1202-1207.
23. Vinores SA, Derevjanik NL, Ozaki H, et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Documenta Ophthalmol 1999;97:217-228.
24. Fishman G, Rhee A, Blair N. Blood-retinal barrier function in patients with cone or cone-rod dystrophy. Arch Ophthalmol 1986;104:545-548.
25. Miyake Y, Goto S, Ota I, et al. Vitreous fluorophotometry in patients with cone-rod dystrophy. Br J Ophthalmol 1984;68: 489-493.
26. Wolf-Schnurrbusch UEK, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 2009;50:3432-3437.